All Stories

  1. Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity
  2. Dual-drug delivery by thermo-responsive Janus nanogel for improved cellular uptake, sustained release, and combination chemo-thermal therapy
  3. Application of nanotechnology in removing laboratory contaminants from the environment
  4. Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer
  5. Systematic review and meta-analysis of the global prevalence of sexually transmitted infections in people living with HIV and associated risk factors
  6. Nanotechnology‐Based Strategies for Extended‐Release Delivery of Angiotensin Receptor Blockers (ARBs): A Comprehensive Review
  7. Unveiling Mesenchymal Stem Cells’ Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications
  8. The future opportunities and remaining challenges in the application of nanoparticle‐mediated hyperthermia combined with chemo‐radiotherapy in cancer
  9. Dynamic alterations in white blood cell counts and SARS-CoV-2 shedding in saliva: an infection predictor parameter
  10. Magnetohyperthermia-synergistic glioma cancer therapy enabled by magnetic graphene oxide nanoheaters: promising nanostructure for in vitro and in vivo applications
  11. Epigenetic memory in breast cancer: electrochemical biosensor-based tracing of histone H3 acetylation inheritance
  12. An update in the applications of exosomes in cancer theranostics: from research to clinical trials
  13. Epigenetic cues regulating airway development in human lung organoids: Polycomb repressive complex 2 and altered chromatin accessibility determine cell fate
  14. Targeted magnetochemotherapy modified by 5-Fu-loaded thermally on/off switching nanoheaters for the eradication of CT26 murine colon cancer by inducing apoptotic and autophagic cell death
  15. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs
  16. The landscape of histone modifications in epigenomics since 2020
  17. Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer
  18. Diagnostic accuracy of clinically applied nanoparticle-based biosensors at detecting SARS-CoV-2 RNA and surface proteins in pharyngeal swabs compared to RT-PCR as a reference test
  19. Symptomatology and microbiology of the gastrointestinal tract in post‐COVID conditions
  20. Type 2 alveolar epithelial cell-derived circulating extracellular vesicle-encapsulated surfactant protein C as a mediator of cardiac inflammation in COVID-19
  21. The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
  22. Adrenal Insufficiency in Patients with Beta-Thalassemia Major in the Southeast of Iran
  23. Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients
  24. Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
  25. Effects of folate-conjugated Fe2O3@Au core–shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies
  26. SARS‐CoV‐2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective
  27. The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks
  28. Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients
  29. Novel Insight Into the Association Between Obesity and Hepatocellular Carcinoma Occurrence and Recurrence: High-Throughput Microarray Data Set Analysis of Differentially Expressed Genes
  30. New Insights into the Importance of Long Non-Coding RNAs in Lung Cancer: Future Clinical Approaches
  31. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer
  32. Counterregulatory Effects of PDE5 Inhibitors on SARS-CoV-2
  33. Application of nanoparticles in cancer therapy with an emphasis on cell cycle
  34. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung
  35. Viral Co‐infections in COVID‐19
  36. Implications of autophagy and apoptosis in tumorgenesis; Possible alterations in autophagy through engineered nanomaterials and their importance in cancer therapy
  37. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection
  38. The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets
  39. Convalescent Blood: Current Perspective on the Efficacy of a Legacy Approach in COVID-19 Treatment
  40. Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review
  41. Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic
  42. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from in vitro to clinical applications
  43. Beneficial Effects of Thymosin α1 in the Treatment of COVID-19
  44. Polymorphism in the 3′-UTR of LIF but Not in the ATF6B Gene Associates with Schizophrenia Susceptibility: a Case-Control Study and In Silico Analyses
  45. COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease
  46. Electrochemical Nano-biosensors as Novel Approach for the Detection of Lung Cancer-related MicroRNAs